Try our corporate solution for free!
(212) 419-8286

Leading global pharmaceutical products by projected revenue 2026

Keytruda, a pharmaceutical product owned by Merck & Co, is forecast to generate some 25 billion U.S. dollars in revenue in 2026. Other prominent pharmaceutical products, such as Eliquis and Opdivo, are also expected to do well that year.

Biotech companies

In 2019, Amgen was the world’s top pure play biotech company, based on market capitalization. The American company had a total market cap of almost 130 billion U.S. dollars that year. In terms of R&D expenditure, Swiss company Roche led the 2019 rankings, spending over 10 billion U.S. dollars. BMS and Johnson & Johnson stood in second and third place and spent a total of 9.4 billion and 8.8 U.S. dollars on research and development combined that year, respectively.

Gilead Sciences

Gilead Sciences, which is headquartered in California, United States, generated 22.5 billion U.S. dollars of revenue in 2019. Gilead Sciences’ top product was Genvoya, which made over 17 percent of the company’s total revenue in 2019. Genvoya is a prescription medicine used to treat HIV-1.

Projected top 10 global pharmaceutical products by revenue in 2026

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

July 2020



Survey time period

as of June 2020

Supplementary notes

Sales represent company reported sales where available, otherwise based on an average of equity analyst estimates.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical market worldwide"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.